Patents Assigned to SYMBIOMIX THERAPEUTICS, LLC
  • Publication number: 20200038372
    Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
    Type: Application
    Filed: September 27, 2019
    Publication date: February 6, 2020
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
  • Publication number: 20200022958
    Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
    Type: Application
    Filed: September 27, 2019
    Publication date: January 23, 2020
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
  • Publication number: 20190255020
    Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
    Type: Application
    Filed: May 3, 2019
    Publication date: August 22, 2019
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: Helen S. PENTIKIS, David PALLING, Carol J. BRAUN
  • Patent number: 10335390
    Abstract: Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: July 2, 2019
    Assignee: Symbiomix Therapeutics, LLC
    Inventors: Helen S. Pentikis, David Palling, Carol J. Braun
  • Publication number: 20190008784
    Abstract: Embodiments described herein are directed to novel soft gelatin capsule formulations for intravaginal administration comprising secnidazole compounds and methods and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.
    Type: Application
    Filed: June 21, 2018
    Publication date: January 10, 2019
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: ROBERT JACKS, LINUS FONKWE, IRENA MCGUFFY
  • Publication number: 20180333391
    Abstract: Method of treating bacterial vaginosis in a subject in need thereof involving administering to the subject a therapeutically effective amount of secnidazole in a microgranule formulation, wherein the microgranule formulation comprises a plurality of microgranules having a volume-weighted particle size distribution within a microgranule population, wherein the volume-weighted particle size distribution as measured from a representative sample of the microgranule population comprises (a) 10% of the microgranule population having a volume-weighted particle size about no less than 470 micrometers; (b) 50% of the microgranule population having a volume-weighted particle size between about no less than 640 micrometers and about no more than 810 micrometers; (c) 90% of the microgranule population having a volume-weighted particle size about no more than 1170 micrometers; or (d) a combination thereof, which can include some or all of (a) through (c) above.
    Type: Application
    Filed: July 30, 2018
    Publication date: November 22, 2018
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: Helen S. PENTIKIS, David PALLING, Carol J. BRAUN, Richard HOLL
  • Publication number: 20160346252
    Abstract: Embodiments described herein are directed to novel pharmaceutical compositions comprising a plurality of microgranules comprising nitroimidazole compounds, and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.
    Type: Application
    Filed: June 1, 2016
    Publication date: December 1, 2016
    Applicant: SYMBIOMIX THERAPEUTICS, LLC
    Inventors: David PALLING, Ronald S. VLADYKA, Joseph AMPREY